Status:
TERMINATED
The Longitudinal Study of Stimulant Use Disorder
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Stimulant Use
Stimulant-Related Disorder
Eligibility:
All Genders
18-85 years
Brief Summary
This research is a 5-year observational, longitudinal registry study with no treatment or medication provided as part of participation. Individuals with current or lifetime stimulant use disorder, in ...
Detailed Description
This project is a five-year observational study that will use a variety of assessments and tasks to phenotype participants with lifetime or current Stimulant Use Disorder as well as healthy control in...
Eligibility Criteria
Inclusion
- Be an adult between the ages of 18-85, inclusive.
- Be able to sufficiently understand, speak, and read English to provide informed consent and ask relevant questions.
- For participants with current/history of Stimulant Use Disorder: Subjects must meet MINI International Neuropsychiatric Inventory (MINI) criteria for current stimulant use disorder or meet MINI supplemental criterial for lifetime stimulant use disorder. For Healthy control individuals: Subjects must meet criteria for a healthy control: No history of substance use disorder or other mental illness as defined by the MINI International Neuropsychiatric Inventory (MINI).
- Be willing to provide consent and comply with all procedure instructions.
- Be willing to provide blood samples and participate in EEGs and MRIs.
Exclusion
- For participants with stimulus use disorder cohort: Have a history of schizophrenia, schizoaffective disorders, or chronic psychotic disorders based on the MINI. For healthy control individuals: Have a history of substance use disorder or any other psychiatric disorder as defined by the MINI and supplemental questions.
- Have any condition for which study participation would not be in their best interest (e.g., cognitive impairment, unstable general medical condition, intoxication, active psychosis) or that could prevent, limit, or confound the protocol-specified assessments, in the opinion of the investigator or their designee.
- Require immediate hospitalization for psychiatric disorder or suicidal risk as assessed by a licensed study clinician.
Key Trial Info
Start Date :
November 16 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2025
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT06073340
Start Date
November 16 2023
End Date
March 31 2025
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UT Southwestern Medical Center
Dallas, Texas, United States, 75247